Background: New antiviral drugs can rapidly improve the symptoms of influenza, but
Introduction
Influenza viral infection increases the risk of hospitalization in infants and young children 1 and sometimes leads to bacterial superinfections with associated complications and accounts for morbididy and mortality 2 . Animal models and molecular microbiologic studies provide evidence for understanding the synergistic effects between influenza viruses and bacteria 3!10 . These studies suggest that some strains of Staphylococcus and Streptococcus 3 and some protease-producing bacteria may increase viral replication and pathogenicity 4 .
However, influenza viruses can directly damage the respiratory epithelium 5, 6 and cause bacterial invasion.
Recent studies have shown that influenza A viral infection also induces immunosuppression, which may cause bacterial superinfection 5, 7, 8, 10 .
Influenza viral infection can now be confirmed with rapid diagnostic kits 11 , and early administration of antiviral agents rapidly relieves symptoms 12 .
There have been no reports on the risk and frequency of bacterial superinfection with such therapy. The purpose of this study was to examine the frequency and effects of bacterial infection in children with influenza being treated with oseltamivir and to determine the necessity of antibiotics.
Materials and Methods

Study Design
To detect bacteria in the throats of patients, Patients were eligible for the study if, at presentation to the hospital, the duration of their fever "$37.5%# was less than 48 hours and they had not received any medication for 1 week.
Patients were not eligible if they were younger than 1 year or had received influenza vaccines for the current season. Patients with any congenital or chronic diseases were also excluded. The parents were given a through explanation of the purpose of the study, and informed consent was obtained.
Control Subjects
Throat swabs for culture were obtained from 109 
Statistical Analysis
Data are expressed as means " SD. We performed a one-way factorial analysis of variance for repeated measurements of variance followed by Fisher!s protected least-significant difference for comparison among means of several groups and Student!s t-test for comparison between two groups. For comparison of category data we performed the χ 2 test. We considered differences significant at p<0.05. All analyses were performed with SPSS 11.0J software (SPSS Inc. USA).
Results
Of 625 patients with influenza, 387 were eligible for the study. Patients with influenza A were younger than patients with influenza B, but the
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male! female ratio and body temperature at the first hospital presentation were not different ( Table 1) .
Throat Culture
Of 387 patients, 210 (54.3%) had pathogens on throat cultures and 177 (45.7%) had normal flora.
Age and body temperature did not differ between these groups ( Table 1 (Fig. 2) .
The pathogenic bacteria groups did not differ significantly in age, except for the penicillin-resistant S. pneumoniae (PRSP) group, which was younger than the other groups ( Table 2) . (27 of 62), p=0.007) (Fig. 1) . The most common isolate was Haemophilus influenzae (69.2%) in controls and S. pneumoniae (33.3%) in selected patients with influenza. The isolates of these two groups were significantly different (p<0.001, Fig. 2 ).
Comparison with Controls
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Clinical Course
The clinical courses of 339 patients were observed, and the results are summarized in Figure 3 Of 198 patients with pathogens, 67 had not received antibiotics for 4 days after treatment with oseltamivir. Of these 67 patients, 27 (40.3%) had fevers for 4 or more days and 40 (59.7%) had fevers F i g . 3 C l i n i c a l c o u r s e . n , n u mb e r o f p a t i e n t s .
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S t r e p t o c o c c u s
There was no difference in the body temperature at the first visit to the hospital between patients with normal flora and those with pathogens.
Therefore, it was difficult to predict the bacterial infection and clinical course from early clinical manifestations.
The detection rate of pathogens was higher in patients with influenza B than in patients with influenza A and differed with the season. These differences may result from the prevalent bacteria strains and different immune responses to influenza A and influenza B viruses 15 .
In the patients with normal flora, the duration of fever after treatment with oseltamivir was 1.6 ! 0.7 days, which was in accord with other reports 12 .
Recent studies have found that strains resistant to oseltamivir did not appear easily 16 . Therefore, resistant strains may not cause prolonged fevers.
The higher detection rate of pathogens suggests an interaction between influenza viruses and bacteria.
We did not obtain blood samples, so it is difficult to know whether bacterial infection was limited to the pharynx or was systemic. However, several studies have reported the synergistic effects of viral and bacterial pathogens 3"10 . These studies were performed in vitro, and more studies may be needed to clarify the synergistic effects of viral and bacterial pathogens in vivo.
In conclusion, bacterial superinfection may cause prolonged fevers in patients with influenza treated with oseltamivir, and antibiotics may be required in these patients.
